News

Health Care Business Award for IBDoc

For the second year, Boussias Communications and Health Daily organized the Healthcare Business Awards 2017 in Greece. The award is meant to showcase and reward innovative healthcare actions. This year the AbbVie Greece received the Gold Award in the Health Innovation category. Together with BÜHLMANN Laboratories AG and the home care provider PCC Hellas AbbVie implemented IBDoc® into

Read more

IBD Patient Care Pathway based on faecal calprotectin

In this video, Dr James Turvill from the York Teaching Hospital introduces and details the York Faecal Calprotectin Care Pathway. He gives a short introduction on the role of calprotectin in stool samples in inflammatory bowel disease (IBD) and its use according to the NICE guidelines. Under his leadership, the local IBD Team developed a Care

Read more

VOX BÜHLMANN No. 8

We are pleased to announce that the first electronic version of our VOX BÜHLMANN is out now. To read the latest news regarding our unique product portfolio click here: VOX BÜHLMANN_DE VOX BÜHLMANN_FR

Read more

New BÜHLMANN CAST® Allergens available!

We are pleased to announce the new 9 BÜHLMANN CAST® Allergens that will reinforce our commitment in the allergy diagnosis. With this release we will strengthen our Hymenoptera venom portfolio with a new dedicated allergen for the European paper wasp, as well as we developed alpha-GAL, a highly standardized allergen to address the new recognized

Read more